This page shows the latest beta thalassaemia news and features for those working in and with pharma, biotech and healthcare.
The companies will work together to develop potentially curative treatments for disorders including sickle cell disease and beta thalassaemia. ... one-time transformative treatment option for diseases including certain haemoglobinopathies such as SCD and
In order to be born with the main form of thalassaemia – beta thalassaemia – a child has to inherit a copy of the faulty beta thalassaemia gene from both parents. ... also a carrier – eg if both parents have the faulty gene that causes beta
progress with our product pipeline, including filing the US biologics licensing application for Beti-cel for beta-thalassaemia,” he added. ... Beti-cel (betibeglogene autotemcel) is a gene therapy for adult, adolescent and paediatric patients with
According to the companies, seven patients with transfusion-dependent beta thalassaemia (TDT), including three who have either a severe or b0/b0 genotype, were transfusion independent at the last follow-up.
210 clinical studies of LentiGlobin for SCD, as well as the holds on the HGB-207 and HGB-212 studies of beti-cel for beta-thalassaemia. ... In relation to its beta-thalassaemia gene therapy Zynteglo, bluebird bio said this would be withdrawn from the
This includes CTX001 – an investigational gene therapy – which has already demonstrated promising early data in transfusion-dependant beta thalassaemia (TDT) and severe sickle cell disease (SCD) patients.
More from news
Approximately 8 fully matching, plus 27 partially matching documents found.
An in-depth look at beta thalassaemia for Rare Disease Day. Beta thalassaemia major is a serious, lifelong genetic blood disorder. ... At least 75, 000 children are born. with thalassaemia worldwide every year, of which 10, 000 have the debilitating form
treatment ozanimod and myelodysplastic syndromes/beta thalassaemia candidate luspatercept – to deliver on their potential.
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...